Events

Videos

Podcasts

Articles

Clinical

® Clinical Focus page includes a listing of all specialities covered across  OncLive.com, including breast cancer, lung cancer, gastrointestinal cancers, genitourinary cancers, hematologic malignancies, and gynecologic cancers. Each individual specialty page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances in both the localized and metastatic settings, and ongoing research.


Tissue Versus Liquid Biopsies in BRAF+ NSCLC

Emerging Therapies and Unmet Needs in BRAF+ NSCLC

Advances in BRAF+ NSCLC: Targeted Therapy

METex14-Mutated NSCLC: Next Steps in Research

Adopting Newer MET Inhibitors Into Practice in NSCLC

Targeted Therapy for METex14-Mutated NSCLC

Treating METex14 Mutations in NSCLC

Tissue Conservation and Liquid Biopsies in NSCLC

Evolution of Molecular Testing in NSCLC

Identifying Rare Mutations in NSCLC

MET as a Driver in NSCLC

Next Steps in Research for BRAF-Mutant NSCLC

Role of ctDNA in NSCLC

Molecular Testing Approaches in NSCLC

Emerging Therapies for BRAF-Mutated NSCLC

Safety Profiles of BRAF/MEK Inhibitors

Treatment Options for BRAF-Mutated NSCLC

BRAF and MEK in NSCLC

Timothy F. Burns, MD, PhD, discusses the frontline standards of care in EGFR-, ALK-, and ROS1-positive non–small cell lung cancer, optimal sequencing strategies, and the nuances of tissue- and plasma-based sequencing.

Overcoming Targeted Therapy Resistance in NSCLC

Daniela Molena, MD, discusses factors that determine if a patient with non–small cell lung cancer is eligible for surgical resection.  
 

Dr. Molena on Determining Surgical Resection Eligibility in NSCLC

The OncLive Lung Cancer condition center page is a comprehensive resource for clinical news and expert insights on non–small cell lung cancer, small cell lung cancer, mesothelioma, and more. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in lung cancer.

Lung Cancer

JAN-22-OSD1275 - /clinical/lung-cancer

Lung Cancer | Specialty